IBIshani Banerji

Ishani Banerji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ishani Banerji has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Avijit Goswami

    AtenPorus Lifesciences, Bangalore 560068, India

    1 shared publication
  • Bartika Ghoshal

    RNA Biology Research Laboratory, Molecular Genetics Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology, Kolkata, India

    1 shared publication
  • Kamalika Mukherjee

    Department of Anesthesiology University of Nebraska Medical Center Omaha Nebraska USA

    1 shared publication
  • Satarupa Ganguly

    RNA Biology Research Laboratory, Molecular Genetics Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology, Kolkata, India

    1 shared publication
  • Shreya Bhattacharjee

    RNA Biology Research Laboratory, Molecular Genetics Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology, Kolkata, India

    1 shared publication
  • Sreemoyee Chakraborty

    RNA Biology Research Laboratory, Molecular Genetics Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology, Kolkata, India

    1 shared publication

Latest Publications

  • Open Access

    Leishmania survives by exporting miR-146a from infected to resident cells to subjugate inflammation

    by Satarupa Ganguly, Bartika Ghoshal, Ishani Banerji, Shreya Bhattacharjee, Sreemoyee Chakraborty, Avijit Goswami, Kamalika Mukherjee, Suvendra N Bhattacharyya

    Leishmania donovani, the causative agent of visceral leishmaniasis, infects and resides within tissue macrophage cells. It is not clear how the parasite infected cells crosstalk with the noninfected cells to regulate the infection process. During infection, Leishmania adopts a dual strategy for its survival by regulating the intercellular transport of host miRNAs to restrict inflammation. The parasite, by preventing mitochondrial function of host cells, restricts the entry of liver cell derived miR-122–containing extracellular vesicles in infected macrophages to curtail the inflammatory response associated with miR-122 entry. On contrary, the parasite up-regulates the export of miR-146a from the infected macrophages. The miR-146a, associated with the extracellular vesicles released by infected cells, restricts miR-122 production in hepatocytes while polarizing neighbouring naïve macrophages to the M2 state by affecting the cytokine expression. On entering the recipient macrophages, miR-146a dominates the miRNA antagonist RNA-binding protein HuR to inhibit the expression of proinflammatory cytokine mRNAs having HuR-interacting AU-rich elements whereas up-regulates anti-inflammatory IL-10 by exporting the miR-21 to polarize the recipient cells to M2 stage.